Clinical Trials Browser

Recruiting × Neoplasms × Immunotherapy, Adoptive × Clear all

NCT05852717 2026-05-06

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Phase 2 Recruiting

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse